Loading...

LYEL LYELL IMMUNOPHARMA INC Company Mergers 8-K Filing

LYLL

LYL

LYELL IMMUNOPHARMA INC

(LYEL)

2025 8-K

Show Summary

Show Summary

Merger of Equals

New Clinical Data

Financial Statements

Facility Closure

Financial Results

Acquisition Completed

Clinical Data Release

Board Resignation

Financial Results

Merger Completion

Merger Agreement

Earnings Report

Phase 1 Trial Data Announce...

Earnings Report

Earnings Reports

Repricing of Underwater Opt...

Financial Results Announcement

Investor Presentation

Earnings Report

Annual Meeting of Stockholders

Resignation of Chief Legal ...

Earnings Report

Earnings Reports

External Links:

On June 20, 2025, Lyell Immunopharma announced that it successfully achieved a clinical milestone with ImmPACT Bio USA, triggering the issuance of 625,000 shares of common stock to ImmPACT's securityholders per their merger agreement.

AI Assistant

LYELL IMMUNOPHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.